Insmed To Present at November 2024 Investor Conferences

Rhea-AI Summary

Insmed (Nasdaq: INSM) has announced its participation in four major healthcare investor conferences in November 2024. The company will present at the Guggenheim Healthcare Innovation Conference in Boston (Nov. 11), UBS Global Healthcare Conference in Rancho Palos Verdes (Nov. 12), Wolfe Research Healthcare Conference in New York (Nov. 20), and Jefferies London Healthcare Conference in London (Nov. 21). All presentations will be webcast live through Insmed's investor relations website and archived for 30 days after the events.

News Market Reaction – INSM

+5.14%

1 alert

+5.14% News Effect

On the day this news was published, INSM gained 5.14%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BRIDGEWATER, N.J., Nov. 6, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences:

• Guggenheim's Inaugural Healthcare Innovation Conference in Boston on Monday, November 11, 2024, at 1:00 p.m. ET.
  
  
• UBS Global Healthcare Conference in Rancho Palos Verdes, Calif., on Tuesday, November 12, 2024, at 11:45 a.m. PT / 2:45 p.m. ET.
  
  
• Wolfe Research Healthcare Conference in New York on Wednesday, November 20, 2024, at 8:00 a.m. ET.
  
  
• Jefferies London Healthcare Conference in London on Thursday, November 21, 2024, at 8:30 a.m. GT / 3:30 a.m. ET.

These events will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events.

About Insmed

Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including a therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company's early-stage research programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.

Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending four consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more.

Contact:

Investors:

Bryan Dunn
Executive Director, Investor Relations
(646) 812-4030
bryan.dunn@insmed.com

Michael V. Morabito, Ph.D.
Director, Investor Relations
(917) 936-8430
michael.morabito@insmed.com

Gianna De Palma
Manager, Investor Relations
(973) 886-2236
gianna.depalma@insmed.com

Media:

Mandy Fahey
Vice President, Corporate Communications
(732) 718-3621
amanda.fahey@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-november-2024-investor-conferences-302296893.html

SOURCE Insmed Incorporated

FAQ

What investor conferences will Insmed (INSM) attend in November 2024?

Insmed will present at four conferences: Guggenheim Healthcare Innovation Conference (Nov. 11), UBS Global Healthcare Conference (Nov. 12), Wolfe Research Healthcare Conference (Nov. 20), and Jefferies London Healthcare Conference (Nov. 21).

How can investors access Insmed's (INSM) November 2024 conference presentations?

Investors can access the live webcasts through Insmed's investor relations website at www.insmed.com. The recordings will be archived for 30 days after each event.

What time is Insmed's (INSM) presentation at the UBS Global Healthcare Conference on November 12, 2024?

Insmed will present at the UBS Global Healthcare Conference at 11:45 a.m. PT / 2:45 p.m. ET on November 12, 2024.

Where can I watch the replay of Insmed's (INSM) November 2024 investor conference presentations?

Presentation replays will be available on Insmed's investor relations website at www.insmed.com for 30 days following each event.